Item 2. Management’s Discussion and Analysis
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
27
Table of Contents
Overview
ScanSource is a leading hybrid distributor connecting devices to the cloud and accelerating growth for customers and channel partners across hardware, software as a service ("SaaS"), and connectivity and cloud services. ScanSource uses multiple sales models to offer hybrid distribution solutions from leading suppliers of specialty technologies and connectivity and cloud services. The Company operates primarily in the United States, Canada and Brazil.
We operate our business under a management structure that enhances our specialty technology focus and hybrid distribution growth strategy. Our segments operate primarily in the United States, Canada and Brazil and are based on sales models:
• Specialty Technology Solutions
• Intelisys & Advisory
We offer hardware, SaaS, and connectivity and cloud services from leading technology suppliers to customers and channel partners enabling solutions for users' needs and challenges. We operate distribution facilities that support our United States and Canada business in Mississippi, California and Kentucky. Brazil distribution facilities are located in the Brazilian states of Paraná, Espirito Santo and Santa Catarina. We provide some of our digital products, which include SaaS and subscriptions, through our digital tools and platforms.
Recent Developments
On August 8, 2024, we completed the acquisition of substantially all of the assets of Secure Path Networks, LLC doing business as Resourcive ("Resourcive"), a leading technology advisor. Resourcive delivers strategic IT sourcing solutions to mid-market and enterprise businesses, advising clients on value creation strategies that are enabled by technology.
On August 15, 2024, we completed the acquisition of substantially all of the assets of Advantix Solutions Group, Inc. ("Advantix"), a managed connectivity experience provider specializing in wireless enablement solutions.
In September 2024, as part of a strategic review of organizational structure and operations, the Company executed a cost reduction and restructuring program to align our cost structure with demand expectations in our hardware business. These actions are expected to result in approximately $10.5 million in annualized savings in selling, general and administrative expenses.
Our Strategy
Our strategy is to drive sustainable, profitable growth by orchestrating hybrid technology solutions through a growing ecosystem of partners by leveraging our people, processes and tools. Our goal is to provide exceptional experiences for our customers, suppliers and employees through operational excellence. Our hybrid distribution strategy utilizes multiple sales models to offer hardware, SaaS, and connectivity and cloud services from leading technology suppliers to customers that solve end-users’ challenges. ScanSource enables customers to deliver solutions for their end-users to address changing buying and consumption patterns. Our solutions may include a combination of offerings from multiple suppliers or give our customers access to additional services. As a trusted adviser to our customers, we provide solutions through our strong understanding of end-user needs. We have plans to continuing expanding our investments in the agency channel in the near term.
28
Table of Contents
Results of Operations
Net Sales
We have two reportable segments, which are based on sales channels. The following tables summarize our net sales results by operating segment and by geographic location for the quarters and six months ended December 31, 2024 and 2023:
Quarter ended December 31, % Change, Constant Currency, Excluding Divestitures and Acquisitions (a)
Net Sales by Segment: 2024 2023 $ Change % Change
(in thousands)
Specialty Technology Solutions $ 723,277 $ 861,514 $ (138,237) (16.0) % (15.4) %
Intelisys & Advisory 24,220 23,278 942 4.0 % (3.2) %
Total net sales $ 747,497 $ 884,792 $ (137,295) (15.5) % (15.1) %
Six months ended December 31, % Change, Constant Currency, Excluding Divestitures and Acquisitions (a)
2024 2023 $ Change % Change
(in thousands)
Specialty Technology Solutions $ 1,475,576 $ 1,715,464 $ (239,888) (14.0) % (13.3) %
Intelisys & Advisory 47,501 45,634 1,867 4.1 % (0.9) %
Total net sales $ 1,523,077 $ 1,761,098 $ (238,021) (13.5) % (12.9) %
(a) A reconciliation of non-GAAP net sales in constant currency, excluding divestitures and acquisitions, is presented at the end of Results of Operations , under Non-GAAP Financial Information.
Specialty Technology Solutions
The Specialty Technology Solutions segment consists of sales to customers primarily in the United States, Canada and Brazil through value-added resellers. For the quarter and six months ended December 31, 2024, net sales decreased $138.2 million, or 16.0%, and $239.9 million, or 14.0%, respectively, compared to the prior-year period. Excluding the impact from foreign exchange rate fluctuations and the impact of divestitures and acquisitions, adjusted net sales decreased $132.7 million , or 15.4%, and $226.9 million, or 13.3%, for the quarter and six months ended December 31, 2024, respectively, compared to the prior-year periods. The decrease in net sales and adjusted net sales for the quarter is primarily due to lower large deals and continued soft demand in a more cautious technology spending environment.
Intelisys & Advisory
The Intelisys & Advisory segment consists of sales to channel partners primarily in the United States through technology services distributors and technology advisors. For the quarter ended December 31, 2024, net sales increased $0.9 million, or 4.0% compared to the prior-year period. Excluding the impact from foreign exchange rate fluctuations and the impact of acquisitions, adjusted net sales decreased $0.7 million, or 3.2%.
For the six months ended December 31, 2024, net sales increased $1.9 million, or 4.1%, compared to the prior-year period. Excluding the impact from foreign exchange rate fluctuations and the impact of acquisitions, adjusted net sales decreased $0.4 million, or 0.9% for the six months ende d December 31, 2024.
The increase in net sales for the quarter and six months ended December 31, 2024 reflects the addition of an acquisition. The slight decrease in adjusted net sales for the quarter and six months is primarily due to lower Intelisys net sales. Quarterly net billings for Intelisys increased 5.0% over the prior-year quarter to bring annualized net billings to approximately $2.77 billion.
29
Table of Contents
Quarter ended December 31, % Change, Constant Currency, Excluding Divestitures and Acquisitions (a)
Net Sales by Geography: 2024 2023 $ Change % Change
(in thousands)
United States and Canada $ 687,111 $ 795,382 $ (108,271) (13.6) % (14.7) %
Brazil (b)
60,386 89,410 (29,024) (32.5) % (18.9) %
Total net sales $ 747,497 $ 884,792 $ (137,295) (15.5) % (15.1) %
Six months ended December 31, % Change, Constant Currency, Excluding Divestitures and Acquisitions (a)
2024 2023 $ Change % Change
(in thousands)
United States and Canada $ 1,399,130 $ 1,586,384 $ (187,254) (11.8) % (12.6) %
Brazil (b)
123,947 174,714 (50,767) (29.1) % (16.0) %
Total net sales $ 1,523,077 $ 1,761,098 $ (238,021) (13.5) % (12.9) %
(a) A reconciliation of non-GAAP net sales in constant currency is presented at the end of Results of Operations in the non-GAAP section.
(b) Countries outside of Brazil represent $0.1 million, or 0.2% of sales, and $0.2 million, or 0.2% of sales, for the quarter and six months ended December 31, 2024, respectively. Countries outside of Brazil represent $1.8 million, or 2.0% of sales, and $4.2 million, or 2.4% of sales, for the quarter and six months ended December 31, 2023, respectively.
30
Table of Contents
Gross Profit
The following table summarizes our gross profit for the quarters and six months ended December 31, 2024 and 2023:
Quarter ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
(in thousands)
Specialty Technology Solutions $ 77,764 $ 77,591 $ 173 0.2 % 10.8 % 9.0 %
Intelisys & Advisory 23,959 23,157 802 3.5 % 98.9 % 99.5 %
Gross profit $ 101,723 $ 100,748 $ 975 1.0 % 13.6 % 11.4 %
Six months ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
(in thousands)
Specialty Technology Solutions $ 156,221 $ 161,854 $ (5,633) (3.5) % 10.6 % 9.4 %
Intelisys & Advisory 47,121 45,402 1,719 3.8 % 99.2 % 99.5 %
Gross profit $ 203,342 $ 207,256 $ (3,914) (1.9) % 13.4 % 11.8 %
Our gross profit is primarily affected by sales volume and gross margin mix. Gross margin mix is impacted by multiple factors, which include sales mix (proportion of sales of higher margin products or services relative to total sales), vendor program recognition (consisting of volume rebates, inventory price changes and purchase discounts) and freight costs. Increases in vendor program recognition decrease cost of goods sold, thereby increasing gross profit. Net sales derived from our Intelisys business contribute 100% to our gross profit dollars and margin as they have no associated cost of goods sold.
Specialty Technology Solutions
For the quarter ended December 31, 2024, gross profit dollars for the Specialty Technology Solutions segment increased $0.2 million, or 0.2%, compared to the prior-year quarter. A more favorable sales mix positively impacted gross profit by $12.6 million, offsetting lower sales volumes of $12.4 million. Gross profit margin increased 175 basis points over the prior-year quarter to 10.8%.
For the six months ended December 31, 2024, gross profit dollars decreased $5.6 million, or 3.5%, compared to the prior-year period. Lower sales volume, after considering the associated cost of goods sold, reduced gross profit dollars by $22.6 million. Gross profit margin increased 115 basis points year-over-year to 10.6%. Gross margin mix positively impacted gross profit by $17.0 million largely due to favorable sales mix and higher vendor program recognition.
Intelisys & Advisory
For the quarter ended December 31, 2024, gross profit dollars for the Intelisys & Advisory segment increased $0.8 million, or 3.5%, compared to the prior-year quarter. Higher sales volume, largely due to the impact of our Advisory business, increased gross profit for the quarter. Gross profit margin decreased 56 basis points compared to the prior-year quarter to 98.9%, reflecting the addition of professional services to the sale mix.
For the six months ended December 31, 2024, gross profit dollars increased $1.7 million, or 3.8%, compared to the prior-year period. Higher sales volume, largely due to the recent Resourcive acquisition, increased gross profit for the six-month period. Gross profit margin decreased 29 basis points compared to the prior-year six-month period to 99.2%, reflecting the addition of professional services to the sales mix.
Operating Expenses
The following table summarizes our operating expenses for the quarters and six months ended December 31, 2024 and 2023:
31
Table of Contents
Quarter ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
(in thousands)
Selling, general and administrative expenses $ 73,920 $ 66,921 $ 6,999 10.5 % 9.9 % 7.6 %
Depreciation expense 2,902 2,964 (62) (2.1) % 0.4 % 0.3 %
Intangible amortization expense 5,001 4,037 964 23.9 % 0.7 % 0.5 %
Restructuring and other charges 313 — 313 100.0 % 0.0 % 0.0 %
Change in fair value of contingent consideration 1,143 — 1,143 *nm 0.2 % 0.0 %
Operating expenses $ 83,279 $ 73,922 $ 9,357 12.7 % 11.1 % 8.4 %
Six months ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
(in thousands)
Selling, general and administrative expenses $ 145,626 $ 142,356 $ 3,270 2.3 % 9.6 % 8.1 %
Depreciation expense 5,759 5,759 — 0.0 % 0.4 % 0.3 %
Intangible amortization expense 9,359 8,230 1,129 13.7 % 0.6 % 0.5 %
Restructuring and other charges 5,381 — 5,381 100.0 % 0.4 % 0.0 %
Change in fair value of contingent consideration 1,143 — 1,143 *nm 0.1 % 0.0 %
Operating expenses $ 167,268 $ 156,345 $ 10,923 7.0 % 11.0 % 8.9 %
Selling, general and administrative expenses (“SG&A”) increased by $7.0 million, or 10.5%, and $3.3 million, or 2.3% for the quarter and six months ended December 31, 2024, respectively compared to the prior-year periods. The increase for the quarter ended and six-month period is primarily attributable to increased customer specific bad debt expense in the United States and Canada, as well as higher costs related to recent acquisitions.
Restructuring and other charges incurred of $0.3 million and $5.4 million during the quarter and six months ended December 31, 2024, respectively, related to employee separation and benefit costs in connection with our expense reduction and restructuring plans implemented during the current fiscal year.
The increase in amortization expense of $1.0 million and $1.1 million during the quarter and six months ended December 31, 2024, respectively, is largely due to intangible assets acquired in our recent acquisitions of Advantix and Resourcive.
We present changes in fair value of the contingent consideration owed to the former shareholders of businesses that we acquire as a separate line item in operating expenses. We recorded a fair value adjustment expense of $1.1 million in the quarter ended December 31, 2024. The expense from change in fair value of contingent consideration for the quarter and six months is largely due to the recurring amortization of the unrecognized fair value discount.
32
Table of Contents
Operating Income
The following table summarizes our operating income for the quarters and six months ended December 31, 2024 and 2023:
Quarter ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
(in thousands)
Specialty Technology Solutions $ 14,077 $ 19,696 $ (5,619) (28.5) % 1.9 % 2.3 %
Intelisys & Advisory 6,440 8,274 (1,834) (22.2) % 26.6 % 35.5 %
Corporate (2,073) (1,144) (929) nm* nm* nm*
Operating income $ 18,444 $ 26,826 $ (8,382) (31.2) % 2.5 % 3.0 %
Six months ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
(in thousands)
Specialty Technology Solutions $ 30,816 $ 37,333 $ (6,517) (17.5) % 2.1 % 2.2 %
Intelisys & Advisory 12,853 14,921 (2,068) (13.9) % 27.1 % 32.7 %
Corporate (7,595) (1,343) (6,252) nm* nm* nm*
Operating income $ 36,074 $ 50,911 $ (14,837) (29.1) % 2.4 % 2.9 %
*nm - percentages are not meaningful
Specialty Technology Solutions
For the Specialty Technology Solutions segment, operating income decreased $5.6 million, or 28.5%, and $6.5 million, or 17.5%, respectively, for the quarter and six months ended December 31, 2024 , respectively, compared to the prior-year periods. Operating margin was at 1.9% and 2.1% for the quarter and six months ended December 31, 2024, respectively. The decrease in operating income for the quarter is primarily due to higher bad debt expense. The decrease in operating income for the six month period is primarily due to lower gross profits from lower sales volumes.
Intelisys & Advisory
For the Intelisys & Advisory segment, operating income decreased $1.8 million, or 22.2%, and $2.1 million, or 13.9%, respectively, for the quarter and six months ended December 31, 2024, respectively, compared to the prior-year periods. Operating margin decreased to 26.6% and 27.1% for the quarter and six months ended December 31, 2024, respectively. The decrease in the quarter and six-month comparative periods is primarily driven by higher employee costs and expense related to the change in fair value of contingent consideration.
Corporate
For the quarter and six months ended December 31, 2024, Corporate operating losses of $2.1 million and $7.6 million, respectively, represent restructuring, acquisition-related costs and a legal settlement incurred in December 2024.
Total Other (Income) Expense
The following table summarizes our total other (income) expense for the quarters and six months ended December 31, 2024 and 2023:
33
Table of Contents
Quarter ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
(in thousands)
Interest expense $ 1,970 $ 3,359 $ (1,389) (41.4) % 0.3 % 0.4 %
Interest income (2,693) (2,119) (574) 27.1 % (0.4) % (0.2) %
Net foreign exchange losses (252) 429 (681) (158.7) % (0.0) % 0.0 %
Gain on sale of business — (14,533) 14,533 nm* — % (1.6) %
Other, net (291) (356) 65 (18.3) % (0.0) % (0.0) %
Total other (income) expense, net $ (1,266) $ (13,220) $ 11,954 (90.4) % (0.2) % (1.5) %
Six months ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
(in thousands)
Interest expense $ 4,078 $ 8,945 $ (4,867) (54.4) % 0.3 % 0.5 %
Interest income (5,352) (3,444) (1,908) 55.4 % (0.4) % (0.2) %
Net foreign exchange losses 83 1,124 (1,041) (92.6) % 0.0 % 0.1 %
Gain on sale of business — (14,533) 14,533 nm* — % (0.8) %
Other, net (5,408) (374) (5,034) nm* (0.4) % (0.0) %
Total other (income) expense, net $ (6,599) $ (8,282) $ 1,683 (20.3) % (0.4) % (0.5) %
*nm - percentages are not meaningful
Interest expense consists primarily of interest incurred on borrowings, non-utilization fees charged on the revolving credit facility and amortization of debt issuance costs. Interest expense decreased for the quarter and six months ended December 31, 2024 compared to the prior-year periods, primarily from lower average borrowings on our multi-currency revolving credit facility.
Interest income increased for the quarter and six months ended December 31, 2024 primarily from interest earned on higher cash balances in the United States.
Net foreign exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign exchange forward contracts gains and losses. Foreign exchange gains and losses are generated as the result of fluctuations in the value of the U.S. dollar versus the Brazilian real, the Canadian dollar versus the U.S. dollar, the euro versus the U.S. dollar, and the British pound versus the U.S. dollar. We partially offset foreign currency exposure with the use of foreign exchange contracts to hedge against these exposures. The costs associated with foreign exchange forward contracts are included in the net foreign exchange losses.
For the quarter and six months ended December 31, 2024, we recognized a gain of $0.3 million and $5.4 million, respectively primarily as a result of an insurance recovery in connection with the cybersecurity attack in the fourth quarter of fiscal year 2023.
Provision for Income Taxes
For the quarter and six months ended December 31, 2024, income tax expense was $2.7 million and $8.6 million, respectively, reflecting an effective tax rate of 13.5% and 20.3%. In comparison, for the quarter and six months ended December 31, 2023, income tax expense was $7.3 million and $11.0 million reflecting an effective tax rate of 18.3% and 18.6%, respectively. The decrease in the effective tax rate for the quarter is primarily due to discrete items. We expect the effective tax rate, excluding discrete items, for fiscal year 2025 to be approximately 28.5% to 29.5%. See Note 13 - Income Taxes to the Notes to Consolidated Financial Statements for further discussion.
34
Table of Contents
Non-GAAP Financial Information
Evaluating Financial Condition and Operating Performance
In addition to disclosing results that are determined in accordance with United States generally accepted accounting principles (“US GAAP” or “GAAP”), we also disclose certain non-GAAP financial measures. These measures include non-GAAP operating income; non-GAAP pre-tax income; non-GAAP net income; non-GAAP EPS; adjusted earnings before interest expense, income taxes, depreciation, and amortization (“adjusted EBITDA”); adjusted return on invested capital (“adjusted ROIC”); and constant currency. Constant currency is a measure that excludes the translation exchange impact from changes in foreign currency exchange rates between reporting periods. We use non-GAAP financial measures to better understand and evaluate performance, including comparisons from period to period.
These non-GAAP financial measures have limitations as analytical tools, and the non-GAAP financial measures that we report may not be comparable to similarly titled amounts reported by other companies. Analysis of results and outlook on a non-GAAP basis should be considered in addition to, and not in substitution for or as superior to, measurements of financial performance prepared in accordance with US GAAP.
Adjusted Return on Invested Capital
Adjusted ROIC assists us in comparing our performance over various reporting periods on a consistent basis because it removes from our operating results the impact of items that do not reflect our core operating performance. We believe the calculation of adjusted ROIC provides useful information to investors and is an additional relevant comparison of our performance during the year.
Adjusted EBITDA starts with net income and adds back interest expense, income tax expense, depreciation expense, amortization of intangible assets, share-based compensation expense, and other non-GAAP adjustments. Since adjusted EBITDA excludes some non-cash costs of investing in our business and people, we believe that adjusted EBITDA shows the profitability from our business operations more clearly.
We calculate adjusted ROIC as adjusted EBITDA, divided by invested capital. Invested capital is defined as average equity plus average daily funded interest-bearing debt for the period. The following table summarizes annualized adjusted ROIC for the quarters ended December 31, 2024 and 2023, respectively:
Quarter ended December 31,
2024 2023
Adjusted return on invested capital ratio, annualized (a)
13.3 % 13.2 %
(a) The annualized EBITDA amount is divided by days in the quarter times 365 days per year, or 366 days for leap year. There were 92 days in the current and prior-year quarter.
The components of this calculation and reconciliation to our financial statements are shown on the following schedule:
35
Table of Contents
Quarter ended December 31,
2024 2023
(in thousands)
Reconciliation of net income to adjusted EBITDA:
Net income (GAAP) $ 17,053 $ 32,726
Plus: Interest expense 1,970 3,359
Plus: Income taxes 2,657 7,320
Plus: Depreciation and amortization 8,132 7,258
EBITDA (non-GAAP) 29,812 50,663
Plus: Change in fair value of contingent consideration 1,143 —
Plus: Share-based compensation 3,021 2,571
Plus: Acquisition and divestiture costs 151 703
Plus: Cyberattack restoration costs 30 441
Plus: Restructuring costs 313 —
Plus: Legal settlement 1,579 —
Plus: Tax recovery (750) (1,386)
Plus: Gain on sale of business — (14,533)
Adjusted EBITDA (numerator for adjusted ROIC) (non-GAAP) $ 35,299 $ 38,459
Quarter ended December 31,
2024 2023
(in thousands)
Invested capital calculations:
Equity – beginning of the quarter $ 920,893 $ 915,253
Equity – end of the quarter 900,662 953,601
Plus: Change in fair value of contingent consideration, net of tax 861 —
Plus: Share-based compensation, net 2,271 1,919
Plus: Acquisition and divestiture costs (a)
151 703
Plus: Cyberattack restoration costs, net 23 329
Plus: Restructuring, net 236 —
Plus: Legal settlement 1,189 —
Plus: Tax recovery, net (2,560) (640)
Plus: Gain on sale of business — (14,533)
Average equity 911,863 928,316
Average funded debt (b)
142,143 227,688
Invested capital (denominator for adjusted ROIC) (non-GAAP) $ 1,054,006 $ 1,156,004
(a) Acquisition and divestiture costs are generally non-deductible for tax purposes.
(b) Average funded debt is calculated as the daily average amounts outstanding on our short-term and long-term interest-bearing debt.
Net Sales in Constant Currency Excluding Acquisitions and Divestitures
We make references to “constant currency,” a non-GAAP performance measure that excludes the foreign exchange rate impact from fluctuations in the average foreign exchange rates between reporting periods. Constant currency is calculated by translating current period results from currencies other than the U.S. dollar into U.S. dollars using the comparable average foreign exchange rates from the prior-year period. We also exclude the impact of acquisitions or divestitures prior to the first full year of operations from the acquisition or divestiture date in order to show net sales results on an organic basis. This information is provided to analyze underlying trends without the translation impact of fluctuations in foreign currency rates and the impact of acquisitions and divestitures. Below we show organic growth by providing a non-GAAP reconciliation of net sales in constant currency excluding acquisitions and divestitures:
36
Table of Contents
Net Sales by Segment:
Quarter ended December 31,
2024 2023 $ Change % Change
Specialty Technology Solutions: (in thousands)
Net sales, reported $ 723,277 $ 861,514 $ (138,237) (16.0) %
Foreign exchange impact (a)
10,723 —
Less: Divestitures — (1,737)
Less: Acquisitions (6,888) —
Non-GAAP net sales $ 727,112 $ 859,777 $ (132,665) (15.4) %
Intelisys & Advisory:
Net sales, reported $ 24,220 $ 23,278 $ 942 4.0 %
Foreign exchange impact (a)
(5) —
Less: Acquisitions (1,685) —
Non-GAAP net sales $ 22,530 $ 23,278 $ (748) (3.2) %
Consolidated:
Net sales, reported $ 747,497 $ 884,792 $ (137,295) (15.5) %
Foreign exchange impact (a)
10,718 —
Less: Divestitures — (1,737)
Less: Acquisitions (8,573) —
Non-GAAP net sales $ 749,642 $ 883,055 $ (133,413) (15.1) %
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2024 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2023.
37
Table of Contents
Net Sales by Segment:
Six months ended December 31,
2024 2023 $ Change % Change
Specialty Technology Solutions (in thousands)
Net sales, reported $ 1,475,576 $ 1,715,464 $ (239,888) (14.0) %
Foreign exchange impact (a)
19,368 —
Less: Divestitures (4,019)
Less: Acquisitions (10,399) —
Non-GAAP net sales $ 1,484,545 $ 1,711,445 $ (226,900) (13.3) %
Intelisys & Advisory
Net sales, reported $ 47,501 $ 45,634 $ 1,867 4.1 %
Foreign exchange impact (a)
(8) —
Less: Divestitures — —
Less: Acquisitions (2,262) —
Non-GAAP net sales $ 45,231 $ 45,634 $ (403) (0.9) %
Consolidated:
Net sales, reported $ 1,523,077 $ 1,761,098 $ (238,021) (13.5) %
Foreign exchange impact (a)
19,360 —
Less: Divestitures — (4,019)
Less: Acquisitions (12,661) —
Non-GAAP net sales $ 1,529,776 $ 1,757,079 $ (227,303) (12.9) %
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2024 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2023.
38
Table of Contents
Net Sales by Geography:
Quarter ended December 31,
2024 2023 $ Change % Change
United States and Canada: (in thousands)
Net sales, as reported $ 687,111 $ 795,382 $ (108,271) (13.6) %
Less: Acquisitions (8,573) —
Non-GAAP Net sales $ 678,538 $ 795,382 $ (116,844) (14.7) %
Brazil:
Net sales, reported (a)
$ 60,386 $ 89,410 $ (29,024) (32.5) %
Foreign exchange impact (b)
10,718 —
Less: Divestitures — (1,737)
Non-GAAP net sales, constant currency $ 71,104 $ 87,673 $ (16,569) (18.9) %
Consolidated:
Net sales, reported (a)
$ 747,497 $ 884,792 $ (137,295) (15.5) %
Foreign exchange impact (b)
10,718 —
Less: Divestitures — (1,737)
Less: Acquisitions (8,573) —
Non-GAAP net sales, constant currency $ 749,642 $ 883,055 $ (133,413) (15.1) %
(a) Countries outside of Brazil represent $0.1 million, or 0.2% of sales, for the quarter ended December 31, 2024 and $1.8 million, or 2.0% of sales, for the quarter ended December 31, 2023.
(b) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2024 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2023.
Six months ended December 31,
2024 2023 $ Change % Change
United States and Canada: (in thousands)
Net sales, as reported $ 1,399,130 $ 1,586,384 $ (187,254) (11.8) %
Less: Acquisitions (12,661) —
1,386,469 1,586,384
Brazil:
Net sales, reported (a)
$ 123,947 $ 174,714 $ (50,767) (29.1) %
Foreign exchange impact (b)
19,360 —
Less: Divestitures — (4,019)
Non-GAAP net sales $ 143,307 $ 170,695 $ (27,388) (16.0) %
Consolidated:
Net sales, reported $ 1,523,077 $ 1,761,098 $ (238,021) (13.5) %
Foreign exchange impact (b)
19,360 —
Less: Divestitures — (4,019)
Less: Acquisitions (12,661) —
Non-GAAP net sales $ 1,529,776 $ 1,757,079 $ (227,303) (12.9) %
(a) Countries outside of Brazil represent $0.2 million, or 0.2% of sales, for the six months ended December 31, 2024 and $4.2 million, or 2.4% of sales, for the six months ended December 31, 2023.
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2024 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2023.
39
Table of Contents
Operating Income by Segment:
Quarter ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
Specialty Technology Solutions: (in thousands)
GAAP operating income $ 14,077 $ 19,696 $ (5,619) (28.5) % 1.9 % 2.3 %
Adjustments:
Amortization of intangible assets 2,740 2,119 621
Change in fair value of contingent consideration 473 — 473
Tax recovery, net (750) (1,386) 636
Non-GAAP operating income $ 16,540 $ 20,429 $ (3,889) (19.0) % 2.3 % 2.4 %
Intelisys & Advisory:
GAAP operating income $ 6,440 $ 8,274 $ (1,834) (22.2) % 26.6 % 35.5 %
Adjustments:
Amortization of intangible assets 2,261 1,918 343
Change in fair value of contingent consideration 670 — 670
Non-GAAP operating income $ 9,371 $ 10,192 $ (821) (8.1) % 38.7 % 43.8 %
Corporate:
GAAP operating loss $ (2,073) $ (1,144) $ (929) nm* nm* nm*
Adjustments:
Acquisition and divestiture costs 151 703 (552)
Restructuring costs 313 — 313
Cyberattack restoration costs 30 441 (411)
Legal settlement 1,579 — 1,579
Non-GAAP operating income $ — $ — $ — nm* nm* nm*
Consolidated:
GAAP operating income $ 18,444 $ 26,826 $ (8,382) (31.2) % 2.5 % 3.0 %
Adjustments:
Amortization of intangible assets 5,001 4,037 964
Change in fair value of contingent consideration 1,143 — 1,143
Tax recovery (a)
(750) (1,386) 636
Acquisition and divestiture costs 151 703 (552)
Restructuring costs 313 — 313
Cyberattack restoration costs 30 441 (411)
Legal settlement 1,579 — 1,579
Non-GAAP operating income $ 25,911 $ 30,621 $ (4,710) (15.4) % 3.5 % 3.5 %
(a) Recovery of prior period withholding taxes in Brazil.
40
Table of Contents
Operating Income by Segment:
Six months ended December 31, % of Net Sales December 31,
2024 2023 $ Change % Change 2024 2023
Specialty Technology Solutions: (in thousands)
GAAP operating income $ 30,816 $ 37,333 $ (6,517) (17.5) % 2.1 % 2.2 %
Adjustments:
Amortization of intangible assets 5,016 4,396 620
Change in fair value of contingent consideration 473 — 473
Tax recovery (a)
(750) (1,386) 636
Non-GAAP operating income $ 35,555 $ 40,343 $ (4,788) (11.9) % 2.4 % 2.4 %
Intelisys & Advisory:
GAAP operating income $ 12,853 $ 14,921 $ (2,068) (13.9) % 27.1 % 32.7 %
Adjustments:
Amortization of intangible assets 4,343 3,834 509
Change in fair value of contingent consideration 670 — 670
Non-GAAP operating income $ 17,866 $ 18,755 $ (889) (4.7) % 37.6 % 41.1 %
Corporate:
GAAP operating loss $ (7,595) $ (1,343) $ (6,252) nm* nm* nm*
Adjustments:
Cyberattack restoration costs 106 640 (534)
Acquisition and divestiture costs 529 703 (174)
Restructuring costs 5,381 — 5,381
Legal settlement 1,579 1,579
Non-GAAP operating income $ — $ — $ — nm* nm* nm*
Consolidated:
GAAP operating income $ 36,074 $ 50,911 $ (14,837) (29.1) % 2.4 % 2.9 %
Adjustments:
Amortization of intangible assets 9,359 8,230 1,129
Change in fair value of contingent consideration 1,143 — 1,143
Cyberattack restoration costs 106 640 (534)
Tax recovery (a)
(750) (1,386) 636
Acquisition and divestiture costs 529 703 (174)
Restructuring costs 5,381 — 5,381
Legal settlement 1,579 — 1,579
Non-GAAP operating income $ 53,421 $ 59,098 $ (5,677) (9.6) % 3.5 % 3.4 %
(a) Recovery of prior period withholding taxes in Brazil.
41
Table of Contents
Additional Non-GAAP Metrics
To evaluate current period performance on a more consistent basis with prior periods, we disclose non-GAAP SG&A expenses, non-GAAP operating income, non-GAAP pre-tax income, non-GAAP net income and non-GAAP diluted earnings per share. Non-GAAP results exclude amortization of intangible assets related to divestitures, cyberattack restoration costs and other non-GAAP adjustments. These year-over-year metrics include the translation impact of changes in foreign currency exchange rates. These metrics are useful in assessing and understanding our operating performance, especially when comparing results with previous periods or forecasting performance for future periods. Below we provide a non-GAAP reconciliation of the aforementioned metrics adjusted for the costs and charges mentioned above:
Quarter ended December 31, 2024
GAAP
Measure Intangible
amortization
expense Change in fair value of contingent consideration Acquisition and Divestiture costs (a)
Restructuring costs Tax
recovery Cyberattack
restoration costs Legal settlement Non-GAAP
measure
(in thousands, except per share data)
SG&A expenses $ 73,920 $ — $ — $ (151) $ — $ 750 $ (30) $ (1,579) $ 72,910
Operating income 18,444 5,001 1,143 151 313 (750) 30 1,579 25,911
Pre-tax income 19,710 5,001 1,143 151 313 (750) 30 1,579 27,177
Net income 17,053 3,745 861 151 236 (2,560) 23 1,189 20,698
Diluted EPS $ 0.70 $ 0.15 $0.04 $ 0.01 $ 0.01 $ (0.11) $ — $ 0.05 $ 0.85
Quarter ended December 31, 2023
GAAP
Measure Intangible
amortization
expense Change in fair value of contingent consideration Acquisition and Divestiture costs (a)
Restructuring costs Tax
recovery Cyberattack
restoration costs Gain on
sale of
a business (b)
Non-GAAP
measure
(in thousands, except per share data)
SG&A expenses $ 66,921 $ — $ — $ (703) $ — $ 1,386 $ (441) $ — $ 67,163
Operating income 26,826 4,037 — 703 — (1,386) 441 — 30,621
Pre-tax income 40,046 4,037 — 703 — (1,386) 441 (14,533) 29,308
Net income 32,726 3,002 — 703 — (640) 329 (14,533) 21,587
Diluted EPS $ 1.29 $ 0.12 $— $ 0.03 $ — $ (0.03) $ 0.01 $ (0.57) $ 0.85
(a) Acquisition and divestiture costs for the quarters ended December 31, 2024 and 2023 are generally nondeductible for tax purposes.
(b) Reflects gain on the sale of the UK-based intY business. This transaction resulted in a capital loss for tax purposes. The Company did not record a tax provision on the capital loss since there were no offsetting capital gains.
42
Table of Contents
Six months ended December 31, 2024
GAAP
Measure Intangible
amortization
expense Change in fair value of contingent consideration Acquisition and Divestiture costs (a)
Restructuring costs Tax
recovery Cyberattack
restoration costs Insurance recovery Legal settlement Non-GAAP
measure
SG&A expenses $ 145,626 $ — $ — $ (529) $ — $ 750 $ (106) $ — $ (1,579) $ 144,162
Operating income 36,074 9,359 1,143 529 5,381 (750) 106 — 1,579 53,421
Pre-tax income 42,673 9,359 1,143 529 5,381 (750) 106 (4,868) 1,579 55,152
Net income 34,028 7,010 861 529 4,054 (2,560) 80 (3,667) 1,189 41,524
Diluted EPS $ 1.39 $ 0.29 $ 0.04 $ 0.02 $ 0.17 $ (0.10) $ — $ (0.15) $ 0.05 $ 1.70
Six months ended December 31, 2023
GAAP
Measure Intangible
amortization
expense Change in fair value of contingent consideration Acquisition and Divestiture costs (a)
Restructuring costs Tax
recovery Cyberattack
restoration costs Insurance recovery Gain on
sale of
a business (b)
Non-GAAP
measure
SG&A expenses $ 142,356 $ — $ — $ (703) $ — $ 1,386 $ (640) $ — $ — $ 142,399
Operating income 50,911 8,230 — 703 — (1,386) 640 — — 59,098
Pre-tax income 59,193 8,230 — 703 — (1,386) 640 — (14,533) 52,847
Net income 48,158 6,121 — 703 — (640) 479 — (14,533) 40,288
Diluted EPS $ 1.91 $ 0.24 $ — $ 0.03 $ — $ (0.03) $ 0.02 $ — $ (0.58) $ 1.60
(a) Acquisition and divestiture costs for the six months ended December 31, 2024 and 2023 are generally nondeductible for tax purposes.
(b) Reflects gain on the sale of the UK-based intY business. This transaction resulted in a capital loss for tax purposes. The Company did not record a tax provision on the capital loss since there were no offsetting capital gains.
43
Table of Contents
Liquidity and Capital Resources
Our primary sources of liquidity are cash flows from operations and borrowings under our $350 million revolving credit facility. Our business requires significant investment in working capital, particularly accounts receivable and inventory, partially financed through our accounts payable to vendors, cash generated from operations and revolving lines of credit. In general, as our sales volume increases, our net investment in working capital increases, which typically results in decreased cash flow from operating activities. Conversely, when sales volume decreases, our net investment in working capital typically decreases, which typically results in increased cash flow from operating activities.
Our cash and cash equivalents balance totaled $110.5 million at December 31, 2024, compared to $185.5 million at June 30, 2024, including $26.0 million and $20.0 million held outside of the United States at December 31, 2024 and June 30, 2024, respectively. Checks released but not yet cleared in the amount of $0.1 million and $5.9 million are included in accounts payable at December 31, 2024 and June 30, 2024, respectively.
We conduct business primarily in the United States, Canada and Brazil where we generate and use cash. We provide for United States income taxes from the earnings of our Canadian and Brazilian subsidiaries. See Note 13 - Income Taxes in the Notes to the Consolidated Financial Statements for further discussion.
Our net investment in working capital, defined as accounts receivable plus inventories less accounts payable, decreased $14.5 million to $520.7 million at December 31, 2024 from $506.2 million at June 30, 2024, primarily from decreases in inventory and accounts receivable, partially offset by lower accounts payable, as a result of lower sales volume reflecting the results of our focus on working capital efficiency improvements. Our net investment in working capital is affected by several factors such as fluctuations in sales volume, net income, timing of collections from customers, increases and decreases to inventory levels and payments to vendors.
Six months ended
December 31,
2024 2023
(in thousands)
Cash provided by (used in):
Operating activities $ 38,642 $ 156,757
Investing activities (58,452) 13,113
Financing activities (52,361) (161,306)
Operating cash flows are subject to variability period over period as a result of the timing of payments related to accounts receivable, accounts payable, and other working capital items. Net cash provided by operating activities was $38.6 million and $156.8 million for the six months ended December 31, 2024 and December 31, 2023, respectively . Cash provided by operating activities for the six months ended December 31, 2024 is primarily attributable to net income adjusted for non-cash items plus reductions in accounts receivable and inventory partially offset by a reduction in accounts payable. Compared to December 31, 2023 , accounts receivable and inventory decreased 17.2% and 14.5% respectively, while accounts payable decreased 3.7%.
The number of days sales outstanding ("DSO") was 66 days at December 31, 2024, compared to 71 days at June 30, 2024 and 68 days at December 31, 2023. Inventory turned 5.2 times during the quarter ended December 31, 2024, compared to 5.0 times during the quarter ended June 30, 2024 and 5.1 times in the prior-year quarter ended December 31, 2023.
Cash used in investing activities for the six months ended December 31, 2024 was $58.5 million, compared to cash provided by investing activities of $13.1 million in the prior-year period. Cash used in investing activities for the six months ended December 31, 2024 is largely due to cash paid for acquisitions and capital expenditures. Cash provided by investing activities for the six months ended December 31, 2023 represents the proceeds from the sale of business offset by capital expenditures.
Management expects capital expenditures for fiscal year 2025 to range from $8.0 million to $12.0 million, prim arily for IT investments.
44
Table of Contents
For the six months ended December 31, 2024 and December 31, 2023 , cash used in financing activities totaled $52.4 million and $161.3 million, respectively. Cash used in financing activities for the six months ended December 31, 2024 is primarily attributable to common stock repurchases in the six months. Cash used in financing activities for the six months ended December 31, 2023 is primarily attributable to repayments of borrowings on the revolving credit facility.
Credit Facility
We have a multi-currency senior secured credit facility with JPMorgan Chase Bank N.A., as administrative agent, and a syndicate of banks (as amended, the “Amended Credit Agreement”). On September 28, 2022, we amended and restated our Amended Credit Agreement, which includes (i) a five-year, $350 million multicurrency senior secured revolving credit facility and (ii) a five-year $150 million senior secured term loan facility. The Amended Credit Agreement extended the credit facility maturity date to September 28, 2027. In addition, pursuant to an “accordion feature,” we may increase our borrowing limits up to an additional $250 million, subject to obtaining additional credit commitments from the lenders participating in the increase. The Amended Credit Agreement allows for the issuance of up to $50 million for letters of credit. Borrowings under the Amended Credit Agreement are guaranteed by substantially all of our domestic subsidiaries and secured by substantially all of our domestic assets. Under the terms of the revolving credit facility, the payment of cash dividends is restricted. We incurred debt issuance costs of $1.4 million in connection with the amendment and restatement of the Amended Credit Agreement. These costs were capitalized to other non-current assets on the Condensed Consolidated Balance Sheets and added to the unamortized debt issuance costs from the previous credit facility.
Loans denominated in U.S. dollars, other than swingline loans, bear interest at a rate per annum equal to, at our option, (i) the adjusted term SOFR or adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon our ratio of (A) total consolidated debt less up to $30 million of unrestricted domestic cash to (B) trailing four-quarter consolidated EBITDA measured as of the end of the most recent year or quarter, as applicable, for which financial statements have been delivered to the Lenders (the “leverage ratio”); or (ii) the alternate base rate plus an additional margin ranging from 0% to 0.75%, depending upon our leverage ratio, plus, if applicable, certain mandatory costs. All swingline loans denominated in U.S. dollars bear interest based upon the adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon our leverage ratio, or such other rate as agreed upon with the applicable swingline lender. The adjusted term SOFR and adjusted daily simple SOFR include a fixed credit adjustment of 0.10% over the applicable SOFR reference rate. Loans denominated in foreign currencies bear interest at a rate per annum equal to the applicable benchmark rate set forth in the Amended Credit Agreement plus an additional margin ranging from 1.00% to 1.75%, depending upon our leverage ratio plus, if applicable, certain mandatory costs.
During the quarter and six months ended December 31, 2024, our borrowings under the Amended Credit Agreement were U.S. dollar loans. The spread in effect as of December 31, 2024 was 1.00% for SOFR-based loans and 0.00% for alternate base rate loans. The commitment fee rate in effect at December 31, 2024 was 0.15%. The Amended Credit Agreement includes customary representations, warranties and affirmative and negative covenants, including financial covenants. Specifically, our Leverage Ratio must be less than or equal to 3.50 to 1.00 at all times. In addition, our Interest Coverage Ratio (as such term is defined in the Amended Credit Agreement) must be at least 3.00 to 1.00 at the end of each fiscal quarter. In the event of a default, customary remedies are available to the lenders, including acceleration and increased interest rates. We were in compliance with all covenants under the credit facility at December 31, 2024.
The average daily outstanding balance on the revolving credit facility, excluding the term loan facility, during the six month periods ended December 31, 2024 and 2023 w as $0.3 million and $138.7 million, respectively. There was $350.0 million and $349.9 million available for additional borrowings as of December 31, 2024 and June 30, 2024, respectively. The effective interest rates for the revolving line of credit were 5.63% and 6.44% as of December 31, 2024 and June 30, 2024, respectively. There were no letters of credit issued under the multi-currency revolving credit facility at December 31, 2024 or June 30, 2024. Availability to use this borrowing capacity depends upon, among other things, the levels of our Leverage Ratio and Interest Coverage Ratio, which, in turn, will depend upon (1) our Credit Facility Net Debt relative to our Credit Facility EBITDA and (2) Credit Facility EBITDA relative to total interest expense, respectively. As a result, our availability will increase if EBITDA increases (subject to the limit of the facility) and decrease if EBITDA decreases. While we were in compliance with the financial covenants contained in the Amended Credit Agreement as of December 31, 2024, and currently expect to continue to maintain such compliance, should we encounter difficulties, our historical relationship with our Amended Credit Agreement lending group has been strong and we anticipate their continued support of our long-term business.
Summary
We believe that our existing sources of liquidity, including cash resources and cash provided by operating activities, supplemented as necessary with funds under our credit agreements, will provide sufficient resources to meet our present and
45
Table of Contents
future working capital and cash requirements for at least the next twelve months. We also believe that our longer-term working capital, planned expenditures and other general funding requirements will be satisfied through cash flows from operations and, to the extent necessary, from our borrowing facilities.
Accounting Standards Recently Issued
See Note 1 of the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements, including the anticipated dates of adoption and the effects on our consolidated financial position and results of operations.
Critical Accounting Policies and Estimates
Critical accounting policies are those that are important to our financial condition and require management's most difficult, subjective or complex judgments. Different amounts would be reported under different operating conditions or under alternative assumptions. See Management's Discussion and Analysis of Financial Condition and Results from Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023 for a complete discussion.
46
Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
For a description of our market risks, see Part II, Item 7A. "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. No material changes have occurred to our market risks since June 30, 2024.
47
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.